- 1Centre for Values, Ethics and the Law in Medicine, Sydney School of Public health, University of Sydney, Level 1, Medical Foundation Building, K25, Sydney, NSW, 2006, Australia, chris.degeling@sydney.edu.au.
Abstract
This article critically examines current responses to multi-drug resistant tuberculosis (MDR-TB) and argues that bioethics needs to be willing to engage in a more radical critique of the problem than is currently offered. In particular, we need to focus not simply on market-driven models of innovation and anti-microbial solutions to emergent and re-emergent infections such as TB. The global community also needs to address poverty and the structural factors that entrench inequalities-thus moving beyond the orthodox medical/public health frame of reference.
No comments:
Post a Comment